A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
Recruiting · NCT07734610 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 1 | 2026-09-23 | NCT07734610 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Floridian Clinical Research, LLC ( Site 0001) | Miami Lakes | United States | 1 |